EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A DPP6 ‐Targeted PET Tracer for Non‐Invasive Imaging of Transplanted Human Islets

Amina Khalil iD, Arturo Roca-Rivada, Svitlana Vasylovska, Lorenzo J I Balestri, Irina Velikyan, Sayro Jawurek, Alexandra C Title, Burcak Yesildag, Luke R Odell, Joey Lau, Decio L Eizirik, Olof Eriksson iD

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11676-11688

DOI: 10.1111/dom.71343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 20.09.2026. Verfasst von Amina Khalil und 11 weiteren Autor:innen. Beteiligte Einrichtung: Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Islets of Langerhans Transplantation, Islets of Langerhans, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helmsley Foundation, Breakthrough Type 1 Diabetes, Walloon Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dipeptidyl peptidase‐like protein 6 (DPP6) is a potential molecular imaging biomarker for pancreatic and transplanted islets of Langerhans. 4hD29 is a single‐domain antibody with nanomolar affinity for DPP6. Here, we demonstrate the generation and validation of [ 68 Ga]Ga‐NOTA‐4hD29 for Positron Emission Tomography (PET) imaging of human stem cell‐derived islets (SC‐islets) and human islets.

Methods

The binding of fluorescently labelled 4hD29 to human islets, human beta cell models and pancreatic tissues from various species over time was characterised. NOTA‐4hD29 was radiolabelled with Gallium‐68, and the resulting tracer [ 68 Ga]Ga‐NOTA‐4hD29 was evaluated for in vitro DPP6 binding as well as in vivo biodistribution. In vivo PET imaging was performed in immunodeficient mice transplanted with 400 to 800 SC‐islets or human islets, and the uptake signal was compared to non‐transplanted control mice.

Results

Fluorescently labelled 4hD29 demonstrated specific binding and internalisation in human islets. Fluorescence signal remained detectable for up to 2 h following incubation, indicating sustained intracellular retention. [ 68 Ga]Ga‐NOTA‐4hD29 bound to human islets with high specificity, and binding intensity correlated to islet purity. The binding of fluorescent and radiolabelled 4hD29 was negligible in extra‐pancreatic tissues. In vivo PET imaging enabled reliable detection of grafts comprised of 400 to 800 SC‐islets or human islets in immunodeficient mice. Conclusion [ 68 Ga]Ga‐NOTA‐4hD29 is a promising PET tracer for in vivo imaging of DPP6 in human islets. The tracer enabled non‐invasive detection of transplanted human islet grafts in the 400–800 IEQ range and demonstrated favourable biodistribution and dosimetry profiles, supporting its further development for islet imaging applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyIslets of Langerhans TransplantationIslets of LangerhansDipeptidyl-Peptidases and Tripeptidyl-PeptidasesHumansAnimalsMiceGallium RadioisotopesTissue DistributionRadiopharmaceuticalsMice, SCIDNerve Tissue ProteinsPotassium Channels

Stichwörter der Autor:innen

DPP6PETbeta cellsimaging reagentsislet transplantationstem cell‐derived islets

Substanzen

Gallium RadioisotopesDipeptidyl-Peptidases and Tripeptidyl-PeptidasesGallium-68DPP6 protein, humanRadiopharmaceuticalsNerve Tissue ProteinsPotassium Channels

Autor:innen und Institutionen

  • Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
  • ULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles, Brussels, Belgium.
  • Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
  • PET Center, Uppsala University Hospital, Uppsala, Sweden.
  • InSphero AG, Schlieren, Switzerland.

ORCID-Profile: Amina Khalil, Olof Eriksson

Förderung

  • Helmsley Foundation
  • Breakthrough Type 1 Diabetes
  • Walloon Region
  • Barndiabetesfonden
  • Diabetesfonden, Science for Life Laboratory, the Swedish Research Council
  • Swedish Cancer Society/Cancerfonden
  • EFSD/Lilly grant, StemTherapy
  • ExoDiab

Zitieren

APA

Khalil, A., Roca-Rivada, A., Vasylovska, S., Balestri, L. J. I., Velikyan, I., Jawurek, S., Title, A. C., Yesildag, B., Odell, L. R., Lau, J., Eizirik, D. L., & Eriksson, O. (2026). A DPP6 ‐Targeted PET Tracer for Non‐Invasive Imaging of Transplanted Human Islets. Diabetes, Obesity and Metabolism, 28(12), 11676-11688. https://doi.org/10.1111/dom.71343

Vancouver

Khalil A, Roca-Rivada A, Vasylovska S, Balestri LJI, Velikyan I, Jawurek S, et al. A DPP6 ‐Targeted PET Tracer for Non‐Invasive Imaging of Transplanted Human Islets. Diabetes, Obesity and Metabolism. 2026;28(12):11676-11688. doi:10.1111/dom.71343

BibTeX
@article{Khalil2026,
  author = {Khalil, Amina and Roca-Rivada, Arturo and Vasylovska, Svitlana and Balestri, Lorenzo J I and Velikyan, Irina and Jawurek, Sayro and Title, Alexandra C and Yesildag, Burcak and Odell, Luke R and Lau, Joey and Eizirik, Decio L and Eriksson, Olof},
  title = {A DPP6 ‐Targeted PET Tracer for Non‐Invasive Imaging of Transplanted Human Islets},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {12},
  pages = {11676--11688},
  doi = {10.1111/dom.71343}
}
Kostenlos starten →